Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Factual Report
$150.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Spectrum Pharmaceuticals appoints Joseph Turgeon as president and chief operating officer - Form 8-K


Thursday, 17 Apr 2014 05:03pm EDT 

Spectrum Pharmaceuticals Inc:Effective April 17, company appointed Joseph Turgeon as president and chief operating officer.On April 17, Ken Keller resigned from his position as executive vice president and chief operating officer.Keller will continue to be employed by company through April 28 in order to assist with the transition.Effective April 17, Tom Riga, currently Vice president, corporate accounts of company, is promoted to position of senior vice president and chief commercial officer.